Alshaer, M.H.; Maranchick, N.F.; Maguigan, K.L.; Shoulders, B.R.; Mousa, M.J.; Murray, M.; Ashton, J.; Alexander, K.; Santevecchi, B.A.; DeSear, K.;
et al. Impact of Timing of Beta-Lactam Therapeutic Drug Monitoring and Therapy Adjustment in Critically Ill Patients. Antibiotics 2025, 14, 463.
https://doi.org/10.3390/antibiotics14050463
AMA Style
Alshaer MH, Maranchick NF, Maguigan KL, Shoulders BR, Mousa MJ, Murray M, Ashton J, Alexander K, Santevecchi BA, DeSear K,
et al. Impact of Timing of Beta-Lactam Therapeutic Drug Monitoring and Therapy Adjustment in Critically Ill Patients. Antibiotics. 2025; 14(5):463.
https://doi.org/10.3390/antibiotics14050463
Chicago/Turabian Style
Alshaer, Mohammad H., Nicole F. Maranchick, Kelly L. Maguigan, Bethany R. Shoulders, Mays J. Mousa, Melissa Murray, Jennifer Ashton, Kaitlin Alexander, Barbara A. Santevecchi, Kathryn DeSear,
and et al. 2025. "Impact of Timing of Beta-Lactam Therapeutic Drug Monitoring and Therapy Adjustment in Critically Ill Patients" Antibiotics 14, no. 5: 463.
https://doi.org/10.3390/antibiotics14050463
APA Style
Alshaer, M. H., Maranchick, N. F., Maguigan, K. L., Shoulders, B. R., Mousa, M. J., Murray, M., Ashton, J., Alexander, K., Santevecchi, B. A., DeSear, K., Venugopalan, V., Cherabuddi, K., & Peloquin, C. A.
(2025). Impact of Timing of Beta-Lactam Therapeutic Drug Monitoring and Therapy Adjustment in Critically Ill Patients. Antibiotics, 14(5), 463.
https://doi.org/10.3390/antibiotics14050463